Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
Sales | 12,274,000 | 12,487,000 | 13,982,000 | 12,348,000 | 9,900,000 |
Cost of Goods | 1,752,000 | 1,794,000 | 3,266,000 | 3,285,000 | 1,980,000 |
Gross Profit | 10,522,000 | 10,693,000 | 10,716,000 | 9,063,000 | 7,920,000 |
Operating Expenses | 7,196,000 | 7,607,000 | 8,682,000 | 6,692,000 | 11,469,000 |
Operating Income | 3,326,000 | 3,086,000 | 2,034,000 | 2,371,000 | -3,549,000 |
Other Income | 102,000 | 43,000 | -1,087,000 | 118,000 | 143,000 |
Pre-tax Income | 3,428,000 | 3,129,000 | 947,000 | 2,489,000 | -3,406,000 |
Income Tax | 582,000 | 809,000 | 334,000 | 250,000 | 269,000 |
Net Income Continuous | 2,844,000 | 2,318,000 | 611,000 | 2,237,000 | -3,674,000 |
Net Income Discontinuous | 19,000 | 13,000 | -10,000 | -2,000 | 83,000 |
Net Income | $2,863,000 | $2,331,000 | $601,000 | $2,235,000 | $-3,591,000 |
EPS Basic Total Ops | 0.38 | 0.31 | -0.03 | 0.29 | -0.48 |
EPS Basic Continuous Ops | 0.38 | 0.31 | 0.02 | 0.29 | -0.49 |
EPS Basic Discontinuous Ops | 0.00 | 0.00 | -0.05 | 0.00 | 0.01 |
EPS Diluted Total Ops | 0.38 | 0.30 | -0.03 | 0.29 | -0.48 |
EPS Diluted Continuous Ops | 0.38 | 0.30 | 0.02 | 0.29 | -0.49 |
EPS Diluted Discontinuous Ops | 0.00 | 0.00 | -0.05 | 0.00 | 0.01 |
EBITDA(a) | $4,582,000 | $4,347,000 | $3,756,000 | $3,469,000 | $-2,613,000 |